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I• President .. .,. 
"What the caterpillar thinks is the end of the world ... the 
butterfly knows is only the beginning." 
-Anonymous 
Institute of Medicine Second Report 
The Institute of Medicine (10M) issued its first report at the end 
of 1999 concerning patient safety and succeeded in getting the 
attention of the public, the third-party payers and the health 
care industry, for a problem that apparently has been around 
for a number of years. In an interview with Dr. Lonnie Bristow, 
former president of the AMA and member of I OM, 
(www.physiciansnews.com) he describes the response of 
industry in forming the Leapfrog group (large Fortune 500 
companies) and restructuring their insurance programs to 
reward those hospitals that are attempting to respond to 
patient safety concerns. He describes the president endorsing 
the safety focus in the VA system and all governmental 
(health) entities. He focused primarily on the second 10M 
report published in March 2001 titled "Crossing the Quality 
Chasm: A new health care system for the 21 5' century." 
"Both reports identify that the problems either with safety or the 
overall quality of care in America lie with the systems of care 
that we give to Americans. That's terribly important. .. Health 
care, as it is rendered in America, frequently was organized in 
a fashion that was for a different time, not for the 21 51 
century ... That's marvelous news because it means that it's not 
really about incompetent physicians or nurses, or uncaring 
hospitals. In fact, the final report states very clearly that we 
are not going to achieve substantial improvement in the quality 
of care by simply exhorting those particular players to work 
harder to make the quality of care better. They can't. .. This is 
good news because it means we can stop beating up on each 
other and begin to look at the systems of care that we use, 
some of which were developed hundreds of years ago, for 
example, the way we write prescriptions." (my underlines) 
The roadmap report goes on to discuss changes in medical 
education, chronic disease management (15 chronic diseases 
to be identified by AHCRQ), and 10 golden rules to guide 
innovation "such as customizing care based on patient needs 
(Continued on Page 2) 
(Continued from Page 1) 
and values, giving patients unfettered access to their own 
medical information, using evidence-based decision-making, 
anticipating patient needs rather than reacting to them, 
decreasing waste of resources or patient time, and ensuring 
cooperation among clinicians and institutions." 
"The need for change? Well, let's take a lesson from nature: 
grow or die." 
-Tor Dahl- Presentation@ Governance Institute 3/27/01 
Does some of the report below seem far-fetched? As Leonard 
Parker Pool said 27 years ago, "look about you." LVH has 
already started the technology metamorphosis. 
A Fully Digital Medical Center is being built in Birmingham by 
HealthSouth Corp. and Oracle Corp. 
The joint venture between the operator of rehabilitation 
hospitals and surgery centers and the software developer will 
feature beds with Internet-linked computer screens, electronic 
medical-record systems, digital imaging instead of traditional 
X-ray film and a wireless communications network to provide 
physicians with real-time information about patients, while 
Internet links to physician offices will enable patients to be 
admitted to the hospital electronically from their doctor's office 
rather than having to wait and fill out paperwork upon arrival, 
the Wall Street Journal reported. The full-service, 218-bed 
hospital is slated for completion by late 2003 and may serve as 
a prototype for as many as ten more to be built in different 
markets over several years, the Journal added, citing Richard 
Scrushy, HealthSouth chairman and chief executive. (Wall 
Street Journal, March 27, 2001) 
http://interactive. wsj.com/articles/SB985645540678313327. htm 
"Hear that sound, Morpheus? ... that's the sound of 
inevitability." 
- Agent Smith in the movie, "The Matrix" 
PA Malpractice Crisis Continues- "We can't fight this alone" -
Dr. Carol Rose 
In the March/April 2001 Supplement to Pennsylvania Medicine: 
"In 2001, forces combined to make the CAT Fund an 
intolerable burden - the hardening of the insurance market, 
increases in premiums and skyrocketing medical liability court 
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awards." Pennsylvania Medical Society President Carol E. 
Rose explains: "After extensive study and consultation with the 
nation's top medical liability experts, your State Society 
concluded that only a multi-stage plan could finally and fully 
solve this very complex problem. • 
She then describes the five-part plan, including immediate 
legislative relief, long term legal reform, a constitutional 
amendment, judicial reforms and a public awareness 
campaign. 
I urge you to contribute to this effort on our behalf and support 
your medical society. If you don't think this is your fight too, 
check your malpractice premium for this year. 
"The Medical Society is the only organization in this fight for 
the long run. We're the only ones in it for our profession, and 
to protect the physician-patient relationship. n 
Never be afraid to try something new. Remember, amateurs 
built the ark, professionals built the Titanic. 
Last month, we expressed real concern (and surprise) about 
the selling of prescribing information - which I now find is 
relatively common. With all the discussion about the upcoming 
Health Insurance Portability and Privacy Act, we expect more 
rulings like the case below: 
A New York Court Ruled that Pharmacists Could Have a Duty 
to Keep Customers' Prescriptions and Medical Histories 
Confidential 
In what is believed to be a first-of-its-kind ruling on a 
pharmacy's role in prescription privacy, the court ruled last 
month that a man with AIDS will be allowed to go forward with 
a lawsuit that claims his privacy was violated when a local 
pharmacy went out of business and sold his records to a 
national chain without his consent, reported AMNews. In 
recent years, physicians have raised concerns that drug 
manufacturers and insurance companies are gaining too much 
access to doctors' prescribing patterns and to patient 
information through prescription records. (American Medical 
News, April2, 2001) 
http://www.ama-assn.om/sci-
pubs/amnews/pick 01 /prsb0402.htm 
E-mail surrogates and GUI- Graphic User Interface (sounds 
kinky - try it, you'll like it) 
(Continued on Page 3) 
(Continued from Page 2) 
The program to communicate with the medical staff on a timely 
basis using e-mail is working. Our feedback indicates that a 
substantial number of the medical staff (or their surrogates) 
read their e-mail. I would like to thank the Physician Relations 
team (POPS} and LVH Information Services for their work in 
this area. We are encouraging all users to employ the GUI 
system for their e-mail. Once again, if you do not pers?nally 
use the e-mail system, designate a surrogate (usually 1n your 
office) to print it for you. The system can work for you- and 
ifs painless. We are declaring cyber-amnesty. Just call Pat 
Skrovanek in Physician Relations at (610) 402-9190. 
You can communicate with medical staff leadership directly via 
e-mail (generally all your suggestions a~d com~ents are.read 
and discussed at Troika}. You have a d1rect vo1ce- albeit, an 
electronic one - but a voice nonetheless to your elected 
representatives who want to know your concerns, issues, and 
views. 
Physicians' Recognition Dinner- 2001 
The March 31 event was a very memorable and enjoyable 
evening for our medical staff. I have received significant 
positive feedback. I would like to thank Dr. Elli~t Sussman and 
Mr. Marv Woodall for their comments. I would like to add 
special thanks to Janet Seifert and ~eth Martin, as. w~ll as the 
entire staff of the Medical Staff Serv1ces office -- Cmd1 Ault, 
Karen Fox, Marge Kratzer, Rita Mest, Kathy Schaeffer, Pat 
Skrovanek, and Lori Tucker. 
Golfer: "Please stop checking your watch all the time, caddy. 
lfs distracting." 
Caddy: "This isn't a watch, sir. It's a compass." 
Edward M. Mullin, Jr., MD 
Medical Staff President 
Physicians Honored for Career Milestones 
Over 60 members of the Lehigh Valley Hospital (LVH) medical 
staff were honored for their years of service, commitment and 
dedication at the 2001 Physician Recognition Dinner held at 
the Holiday Inn Conference Center, Fogelsville, on March 31. 
Edward M. Mullin, Jr., MD, President of the LVH medical staff, 
told more than 300 physicians, board members, hospital 
administrators and guests that his colleagues were being 
recognized for their service to patients and the community in 
partnership with LVHHN. "We've chosen a demanding field 
only we can truly understand. All of us can take satisfaction in 
this accomplishment. • 
Receiving special recognition were past presidents of the . 
medical staff, physicians who served 50 years on the med1cal 
staff and those who served 25 years. 
Past presidents who were honored include David M. Caccese, 
MD, Department of Medicine, Division of General Internal 
Medicine, and Robert X. Murphy, Jr., MD, Department of 
Surgery, Division of Plastic Surgery. 
Honored for 50 years of service were Charles D. Schaeffer, 
MD, Department of Surgery, Division of General Surgery.' ~~d 
Lawrence M. Weisbrod, MD, Department of Surgery, D1v1s1on 
of Orthopedic Surgery. 
Those honored for 25 years of service include: 
Department of Anesthesiology 
•!• ln·Ho Chang, MD 
•!• Ramon J. Deeb, MD 
•!• Howard E. Hudson, Jr., MD 
•!• Jay S. Jung, MD 
•!• Samuel M. Lerner, MD 
•!• Carmen B. Montaner, MD 
•!• Toeruna S. Wldge, MD 
•!• Wen-Shiong Yang, MD 
DepartmentofDentis&y 
•:• Russel S. Bleiler, Jr., DDS, Division of General 
Dentistry/Special Care 
•!• Peter T. Davis, DDS, Division of Prosthodontics 
•!• Michael F. Lentz, DDS, Division of General 
Dentistry/Special Care 
•:• Dominic P. Lu, DDS, Division of General 
Dentistry/Special Care 
Department of Emergency Medicine 
•:• Joseph J. Fassl, MD 
•:• Ronald A. Lutz, Sr., MD 
(Continued on Page 4) 
(Continued from Page 3) 
Department of Family Practice 
•!• LeRoy B. Gerchman, MD 
•!• Dennis M. McGorry, DO, Section of Geriatrics 
•!• John J. Mecca, MD 
Department of Medicine 
•!• Lloyd E. Barron II, MD, Division of Hematology-Medical 
Oncology 
•!• Ki T. Boo, MD, Division of General Internal Medicine 
•!• Charles M. Brooks, MD, Division of Gastroenterology 
•!• David M. Caccese, MD, Division of General Internal 
Medicine/Geriatrics 
•!• Joseph V. Episcopio, MD, Division of General Internal 
Medicine 
•!• Peter K. Ghatak, MD, Division of General Internal 
Medicine 
•!• Robert W. Grunberg, MD, Division of Nephrology 
•!• John B. Longenhagen, MD, Division of General Internal 
Medicine 
•!• John K. Mahon, MD, Division of Neurology 
•!• James A. Pantano, MD, Division of Cardiology 
•!• Robert M. Post, MD, Division of Hematology-Medical 
Oncology 
•!• Cynthia D. Starr, MD, Division of Hematology-Medical 
Oncology 
Department of Obstetrics and Gynecology 
•!• Ernest Y. Normington II, MD, Division of Primary 
Obstetrics and Gynecology 
Department of Pathology 
•!• Arthur A. Altman, MD, Division of Anatomic Pathology 
•!• Raymond A. Rachman, MD, Division of Anatomic 
Pathology 
•:• Michael Scarlato, MD, Division of Anatomic Pathology 
•!• John J. Shane, MD, Division of Anatomic Pathology 
Department of Pediatrics 
•!• Martha A. Lusser, MD, Section of Neurology 
•!• Charles F. Smith, MD, Division of General Pediatrics 
Department of Psychiatry 
•!• Paul K. Gross, MD, Division of Adult Inpatient Psychiatry 
Department of Radiology-Diagnostic Medica/Imaging 
•!• Stanley Benzel, MD, Division of Diagnostic Radiology 
•!• Robert Kricun, MD, Division of Diagnostic Radiology 
•!• Thomas E. Leet, MD, Division of Diagnostic Radiology 
•!• Zwu S. Lin, MD, Division of Diagnostic Radiology 
•!• Alan H. Wolson, MD, Division of Diagnostic Radiology, 
Section of Chest 
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Department of Surge~ 
•!• George A. Arangio, MD, Division of Orthopedic Surgery, 
Section of Ortho Trauma 
•!• Pricha Boonswang, MD, Division of Colon and Rectal 
Surgery 
•!• Tamar D. Earnest, MD, Division of General Surgery 
•!• J. Victor Ehrens, DMD, Division of Oral and Maxillofacial 
Surgery 
•!• Walter J. Finnegan, MD, Division of Orthopedic Surgery 
•:• William W. Frailey, Jr., MD, Division of General Surgery 
•!• Charles S. McConnel, Jr., MD, Division of 
Otolaryngology-Head & Neck Surgery 
•!• Kenneth M. McDonald, MD, Division of Vascular Surgery 
•!• Edward M. Mullin, Jr., MD, Division of Urology 
•!• Farrokh S. Sadr, MD, Division of Cardia-Thoracic Surgery 
•!• Charles J. Scagliotti, MD, Division of General 
Surgery/Trauma-Surgical Critical Care 
•!• Paul H. Schenck, MD, Division of Ophthalmology 
•!• John J. Stasik, MD, Division of Colon and Rectal Surgery 
•!• David B. Sussman, MD, Division of Orthopedic Surgery, 
Section of Ortho Trauma 
•!• William M. Trachtenberg, MD, Division of Ophthalmology 
•!• Howard D. Trimpi, MD, Division of Colon and Rectal 
Surgery 
The Physician Recognition Dinner is held every three years to 
recognize and acknowledge the countless efforts and 
contributions made by physicians to Lehigh Valley Hospital 
and Health Network. This year's dinner was the first since the 
medical staffs of Lehigh Valley Hospital and Lehigh Valley 
Hospital-Muhlenberg merged in December 1998. 
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Radiology News 
PET Scanning Has Arrived! 
Positron Emission Tomography (PET) is now available at 
Lehigh Valley Hospital, Cedar Crest & 1-78. CDL Medical 
Technologies has been contracted to provide mobile PET 
services to LVH. The system that has been chosen is a state-
of-the-art Siemen's dedicated PET scanner which can detect 
lesions as small as several millimeters. Scanning will initially 
be performed one day per week with the potential of expanded 
services as volume builds. 
The clinical usefulness of PET will mainly be in the field of 
oncology. PET utilizes an isotope of glucose, i.e., 2-deoxy-2-
[1BF] fluoro-D-glucose (FDG). Since most tumors have high 
glyolytic rates, FDG uptake is seen in many tumors. PET FDG 
has been shown to detect tumor foci of a variety of histologic 
types. 
PET is unique in providing functional assessment of the 
anatomic abnormalities usually found on CT or MRI scans. 
Studies indicate that PET may be used as a compliment to CT 
by helping to characterize, as benign or malignant, solitary 
pulmonary nodules found to be indeterminate on CT. By 
reducing false-positive studies, radiologists can more 
accurately identify patients for surgical resection and decrease 
unnecessary interventions for benign nodules. 
PET is important in tumor staging. For example, in the 
evaluation of a patient with non-small cell lung cancer, 
accurate evaluation of the mediastinum is important for staging 
and treatment decisions. PET can detect tumors in normal 
sized lymph nodes and, therefore, more accurately stage 
patients with lung cancer. PET can improve the sensitivity and 
specificity for mediastinal staging of these patients. 
PET also has been shown to increase accuracy in detecting 
recurrent disease in patients with colorectal cancer and 
melanoma. PET can detect small tumor foci in patients with 
colon cancer with a rising CEA level and a normal or equivocal 
CT scan. PET can help stage Hodgkin's and non-Hodgkin's 
lymphoma much better than Gallium scans. 
There are some limitations to PET scanning. Although 
specificity is usually high, inflammatory or infectious processes 
may result in false-positive interpretations. Also, PET does not 
provide the level of precise anatomic localization of tumor 
required for surgical excision or targeted radiation therapy and 
requires complimentary anatomic correlation with CT or MRI. 
The relative amount of radiation to a patient from a PET FDG 
scan is similar to that of a body computed tomography scan. 
PET scans are currently approved by HCFA for the following 
indications: 
~ Characterization of solitary pulmonary nodules 
~ Initial staging and follow-up of: 
• non-small cell lung cancer 
• colorectal cancer 
• melanoma 
• Hodgkin's and non-Hodgkin's lymphoma 
These studies will be interpreted by Nuclear Medicine 
physicians, Robert Rienzo, MD, and Kathleen McDonald, MD, 
who are board certified by both the American Board of 
Radiology and the American Board of Nuclear Medicine. 
If you have any questions concerning PET, please contact 
either Dr. Rienzo or Dr. McDonald in Nuclear Medicine at (610) 
402-8373. 
(Some of the information in this article was obtained from the Oncology 
Roundtable of the Advisory Board Company of Washington, D. C.) 
Nuclear Medicine Reminder 
Federal and State regulations governing the medical use of 
radioactive materials define a misadministration as one 
involving administration of a radiopharmaceutical (1) to the 
wrong patient, (2) involving the wrong route of administration, 
or (3) administration of a radiopharmaceutical other than the 
one intended or prescribed. Misadministrations compromise 
patient care, as well as representing significant violations of 
our radioactive materials license conditions. 
Prevention of misadministrations requires diligence by all 
parties with respect to making certain that the clinical objective 
of all diagnostic exams or radiopharmaceuticals are 
understood and met. 
Toward this end, all referrals for radiopharmaceutical-based 
procedures must be made by prescription. Also, please stress 
to your patients that they present the prescription to the 
attending Nuclear Medicine technologist at the time of their 
exam. No procedure will be preformed without a 
prescription. 
Thank you for your attention to this issue. If you have any 
questions, please contact Bernard Valasek, Nuclear Medicine 
Technologist (Cedar Crest & 1-78), at (610) 402-8390, or 
Sandra Bobryk, Lead Technologist, Nuclear Medicine (LVH-
Muhlenberg), at (484) 884-2235. 
Please Note • The telephone number for the Nuclear 
Medicine Physicians' Viewing Room at Cedar Crest & 1-78 
has been changed to (61 0) 402·8373. 
News from CAPOE Central 
Several weeks ago, I was demonstrating the CAPOE system 
to a group of doctors. They were impressed by the capabilities 
of the system, including the ability to look up and re-activate 
orders from previous admissions, the use of order sets, and 
the allergy and drug interaction checking. However, like many 
of the medical staff, one of them was concerned about the time 
required to enter orders into the computer. He wrote out eight 
separate orders and handed them to me. "Now, enter these as 
quickly as you can," he challenged. I would have complied, 
but I could not read the first two orders he had written (and 
neither could one of the other people in the room}. I was 
tempted to page him an hour later to ask him for clarification of 
his orders (as would have happened in the hospital}. 
A recent report was released by the Agency for Healthcare 
Research and Quality entitled, "Research in Action: Reducing 
and Preventing Adverse Drug Events (ADE} to Decrease 
Hospital Costs.· Highlights from the report follow: 
• Incidence rates of ADEs vary from 2 per 100 admissions 
to 7 per 1 00 admissions among the hospitals that have 
conducted ADE studies. 
• Anywhere from 28 percent to 95 percent of ADEs can be 
prevented by reducing medication errors through 
computerized monitoring and order entry systems. 
• For example, at least two studies attribute 42-60 percent 
of ADEs to excessive drug dosage for the patient's age, 
weight, underlying condition, and renal function. 
• According to another AHRQ-funded study at Brigham and 
Women's Hospital, computerized medication order entry 
has the potential to prevent an estimated 84 percent of 
dose, frequency, and route errors. Their system, which is 
similar to our CAPOE system, eliminates illegible orders 
that lead to medication errors. Programmed within the 
system are algorithms that check dosage frequency, 
medication interactions, and patient allergies. 
• Patients who experienced adverse drug events (ADEs} 
were hospitalized an average of 8 to 12 days longer than 
patients who did not suffer ADEs, and their hospitalization 
cost $16,000 to $24,000 more. 
• Hospitals can save as much as $500,000 annually in 
direct costs by using computerized systems. 
The literature continues to provide evidence that physician 
order entry improves the quality of care. I believe that with 
CAPOE, we are on the correct path to achieve this goal while 
having an overall beneficial impact on the work process of our 
physicians/providers. 
We will provide an opportunity for true "hands-on" experience 
with CAPOE outside the Cedar Crest & 1-78 Auditorium all day 
on Tuesday and Wednesday, May 8 and 9. There will be live 
demonstrations and workstations set up to provide physicians 
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and staff an opportunity to "play with the system. • Please stop 
by and give it a test drive. 
Don Levick, M.D., MBA 
(484} 884-4593 
(610} 402-5100 7481 (pager} 
Recommendation from the Therapeutic 
(Transfusion) Committee: Blood 
Infusion Rates 
By Bala B. Carver, MD, Chief, Section of Transfusion Medicine & HLA 
Red Blood Cells: 
In a clinically stable patient, red blood cells should be 
infused over 1.5-2 hours. 
It was brought to the committee's attention that many 
transfusions are being given over 3-4 hours. Blood is 
an excellent culture medium and, at room 
temperature, the potential of bacterial growth exists 
which is directly proportional to the length of time the 
blood is at room temperature. 
If rapid transfusion is needed, blood can be infused 
as rapidly as the patient's circulatory system will 
tolerate, and the type of vascular access will allow. If 
there is a concern about the fluid status of the patient 
and a slower transfusion is required, either the unit 
should be divided into two or the patient should be 
premedicated with a diuretic. 
Other Blood Components (e.g., fresh frozen plasma, 
platelets, cryoprecipitate): 
These other components can be infused as rapidly as 
the patient will tolerate. 
The infusion rate needs to be ordered for each transfusion on 
the Blood Component Transfusion Order form. 
If you have any questions regarding this issue, please contact 
Bala B. Carver, MD, Chief, Section of Transfusion Medicine & 
HLA, at (610} 402-8142. 
Physician Assistant Order Writing 
Recently, a number of questions have been raised as to what 
physician assistants can do. The following list of medications 
can be prescribed by a physician assistant, if so delegated by 
a physician assistant supervisor (a physician who is identified 
as the supervising physician of a physician assistant in the 
written agreement and is registered with the Medical Board as 
such). Written agreements need to be submitted to the 
Medical Staff Office. 
);> Antihistamines 
);> Anti-infective agents 
);> Cardiovascular drugs 
);> Contraceptives - eg: foams and devices 
);> Diagnostic agents 
);> Disinfectants -for agents used on objects other then skin 
);> Electrolytic, caloric and water balance 
);> Enzymes 
);> Antitussives, expectorants, mucolytic agents 
);> Gastrointestinal agents 
);> Local anesthetics 
);> Serums, toxoids and vaccines 
);> Skin and mucous membrane agents 
);> Smooth muscle relaxants 
);> Vitamins 
Categories from which Physician Assistants May 
Prescribe (subject to exclusions and limitations listed) 
Autonomic drugs 
Drugs excluded under this category: 
);> Sympathomimetic (adrenergic) agents 
Blood formation and coagulation 
Drugs excluded under this category: 
);> Anti-coagulants and coagulants 
);> Thrombolytic agents 
Central Nervous System agents 
Drugs excluded under this category: 
);> General anesthetics 
);> Monoamine oxidase inhibitors 
Eye, ear, nose and throat preparations 
Drugs limited under this category: 
);> Miotics and mydriatrics used as eye preparations require 
specific approval from the physician assistant supervisor 
for a named patient. 
Hormones and synthetic substitutes 
Drugs excluded under this category: 
);> Pituitary hormones and synthetics 
);> Parathyroid hormones and synthetics 
Categories from which Physician Assistants May Not 
Prescribe or Dispense 
);> Antineoplastic agents 
);> Dental agents 
);> Gold compounds 
);> Heavy metal antagonists 
);> Oxytocics 
);> Radioactive agents 
);> Unclassified therapeutic agents 
);> Devices 
);> Pharmaceutical aids 
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A physician assistant may not prescribe or dispense Schedule 
1 or II controlled substances (i.e., Morphine, Percocet, etc.) 
A physician assistant may not prescribe whole blood and blood 
components. 
It is important to understand what physician assistants may or 
may not do. If an order is written for a medication or blood 
product which is not approved according to the State Rules 
and Regulations, a nurse cannot act on the order, the Blood 
Bank cannot dispense the blood, or the Pharmacy cannot 
dispense the medication, unless co-signed by the physician 
assistant supervisor. 
If you have any questions or concerns regarding this issue, 
please contact Rita M. Mest, Director, Medical Staff Services, 
at (610) 402-8975, or Fred J. Pane, R.Ph., Director, Pharmacy, 
at (610) 402-8882. 
A Word About Consults 
By David M. Caccese, MD, Division of General Internal Medicine/Geriatrics 
Envision the following all too common scenario: You've been 
working at the hospital and in your office all day. You started 
rounds at the hospital at 7 a.m. After a long afternoon in the 
office, you do get home to have dinner with your family. Since 
you are on call for your group, you have to go back to the 
hospital after dinner to evaluate and admit two patents that are 
in the emergency room. Finally, at 10:30 p.m., you are able to 
leave the hospital and drive home. You're fatigued after a long 
day, but are hopeful that the remainder of the night "won't be 
too bad." 
Shortly after getting home and turning on the 11 p.m. news, 
your pager goes off with a message to call your answering 
service. You call immediately and are told by the answering 
service operator that there is an "urgent consult" at LVH. The 
consult request simply says "please see tonight!" No other 
information is given, other than the name of the patient's 
attending physician, and patient's room location. 
Think about the reaction that all of us have had in this 
unfortunately, not uncommon situation. First, there is a rapid 
rise in systemic catecholanine levels. Anger follows. This is 
frequently followed by an expletive. Then the questions begin: 
"What is wrong with the patient?" "Why do I need to see the 
patient tonighr?" "Do I really need to see the patient tonighr?" 
"Why didn't the doctor who wanted me to see his/her patient 
tonight call me to tell me what this was all about?" 
All of us have been confronted with the above scenario at some 
point in our careers. What is the answer for this problem? One 
word helps to diffuse the issue-- COMMUNICATION!! 
We are professionals. We expect and want to be treated as 
professionals by our patients, our nursing colleagues in the 
hospital, and especially by our physician colleagues. How 
much better would it be for us as individual physicians if the 
above scenario did not occur as frequently as it does? 
Wouldn't it be better for patient care (and physician 
catecholamine levels) if the physician requesting an urgent 
consultation had the courtesy and respect for his professional 
colleague to call him/her and tell him why he was requesting 
an urgent consultation on the patient? The requesting 
physician might be able to provide important historical 
information, and most importantly, would be able to ask the 
question which the consultant was to address in an urgent 
fashion. 
Communication between professionals could help to build a 
better working relationship. It might even result in a long 
lasting referral relationship that could benefit both parties. 
Most of all, it would improve the quality of patient care. Think 
about it! 
Sleep Disorders Center Relocating to 
17th & Chew 
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On May 1, the Sleep Disorders Center, which has been 
located at Cedar Crest & 1-78, will move to the fourth floor of 
Lehigh Valley Hospital at 17th & Chew. The new laboratory, 
with improved diagnostic equipment, will expand from its 
current six beds to 13 beds effectively doubling the ability to 
perform sleep studies. In addition to expanding in capacity, 
the new Center will offer significant improvements in comfort to 
patients including a private bath with a shower in each room, 
televisions, refreshment center, and attractive "hotel room" 
decor. For patients' convenience, valet parking will be 
available at the front entrance of the hospital. 
To schedule an appointment, please contact Central 
Scheduling at (610) 402-8378 (TEST). For information about 
sleep studies, please contact the Sleep Disorders Center at 
(610) 402-9777. 
'"· ·, . ._,' ' 
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Central Scheduling to Handle Reservations 
for MRI and Sleep Disorder Studies at L VH-M 
Beginning April 30, the Central Scheduling Department will 
handle reservations for MRI and Sleep Disorder Studies at 
LVH-Muhlenberg. Previously, the individual departments 
handled the scheduling of reservations. This change is part of 
the continuing effort to streamline access to the services 
available at LVH-Muhlenberg. 
In order to expedite the scheduling process, please have the 
patient's demographic information, including their insurance 
information, available at the time of the scheduling call. As 
with the other tests and procedures you order through Central 
Scheduling, this will allow patients to be pre-registered and 
speed the intake process when they arrive at the hospital. 
To schedule an MRI or Sleep Disorder Study at LVH-
Muhlenberg, please call Central Scheduling at (484) 884-2279, 
Monday through Friday, from 7 a.m. to 7 p.m. 
If you have any questions, comments or concerns, please 
contact Lisa Coleman, Director, Support Services, at (610) 
402-8066, or Mark Holtz, Vice President of Operations, at 
(484) 884-4710. 
Infection Control News 
Animal bites are listed as reportable diseases in the 
Commonwealth of Pennsylvania. Health care providers are 
required to immediately report all types of animal bites to 
their local Health Bureau. This includes all warm-blooded and 
cold-blooded animals (snakes and other reptiles). Rapid 
reporting of animal bites assists the Health Bureau in helping 
to identify dangerous animals and removing them from the 
community, if necessary, or by requiring owners to properly 
restrain and vaccinate pets. Reportable disease forms are 
available from the Health Bureau. 
Allentown Health Bureau 
245 N. 61h Street 
Allentown, PA 18102 
Phone: (610) 437-7577 
Page: (610) 218-3266 
Fax: (610) 437-8799 
Bethlehem Health Bureau 
10 E. Church Street 
Bethlehem, PA 18018 
Phone: (610) 865-7087 
Fax: (610) 865-7019 
Lehigh County PA·DOH 
3730 Lehigh Street 
Whitehall, PA 18052 
Phone: (610) 821-6770 
Emergencies: (717) 826-2062 
Fax: (610) 821-6564 
If you have any questions regarding this issue, please contact 
a member of the Infection Control Department at (61 0) 402-
0680. 
Osteoporosis: Could Your Patients Be 
At Risk? 
Osteoporosis arises when the balance between bone 
formation and bone resorption is disrupted in favor of bone 
resorption. It is a widespread condition affecting more than 28 
~illion individu~ls in the U.S. In a demographic analysis of a 
mne county reg1on of Pennsylvania (including Lehigh County) 
conducted a few years ago, one-third of all women and men 
age 45-75+ were found to have osteoporosis or to have low 
bone mass and be at risk for osteoporosis. As a silent risk 
factor for fracture, osteoporosis represents a major cause of 
morbidity, hospitalization and mortality. One of every two 
white women will experience an osteoporotic fracture 
sometime in her lifetime. 
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Osteoporosis is a multifactorial condition with well-recognized 
risk factors. These include: age, gender, genetics, body size, 
lifestyle factors, other illnesses and drug treatments. Bone 
density declines after age 30, particularly in post-menopausal 
women. While the lighter and smaller skeleton of women 
make them more likely to develop osteoporosis, 20% of all 
people with osteoporosis are men. Caucasians and Asians 
have a higher prevalence of osteoporosis. Excessive alcohol 
consumption, tobacco use, sedentary lifestyle, and a diet low 
in calcium increase the risk for osteoporosis. Illnesses that 
speed bone loss or cause immobility increase risk. 
Medications that affect bone metabolism include: 
Glucocorticoids, Adrenocorticotrophin, excessive use of 
Thyroxine, Anticonvulsants, long term Heparin use, Lithium, 
Cytotoxic drugs (Methotrexate), Aluminum, Gonadotrophin-
releasing hormone agonists, and Cyclosporin A. Early 
identification of individuals at risk and implementation of 
preventative measures, where possible, can result in 
minimization of bone loss, better skeletal preservation, and 
reduction in fracture risk. 
Osteoporosis is not an inevitable aspect of aging, but 
preventative efforts need to be lifelong. Individuals must be 
assessed in terms of their medical history and predisposing 
factors to determine their risk for low bone mass. Because 
bone mass in men and women increases until about age 30 
before beginning to decline, efforts in this population should be 
directed toward maximizing peak bone mass. After age 30, 
efforts must be directed toward preventing bone loss. Adults 
with vertebral, rib, hip or distal forearm fractures should be 
ev~luated for osteoporosis via bone mineral density testing. 
Umversal recommendations to maximize and preserve bone 
mass include: adequate intake of calcium and vitamin D, 
regular ~eight bearing and muscle-strengthening exercises, 
and avo1dance of both tobacco use and excessive alcohol 
intake. 
May is National Osteoporosis Prevention Month. Regardless 
of the age of your patients, it is never too soon or too late to 
think about bone health. The National Osteoporosis 
Foundation's annual prevention campaign message for 2001 
emphasizes the consequences of osteoporosis and the need 
for all healthcare practitioners to take a preventative approach 
with their patients -- "Every 20 seconds osteoporosis causes a 
fracture." 
If you are interested in more information related to 
osteoporosis or bone mineral density testing, please contact 
the Metabolic Bone Program at the Health Center at 
Trexlertown at (610) 402-WELL. 
(So~rce: National Osteoporosis Foundation & Osteoporosis Learning 
Senes: ACME-accredited self-study program} 
Experience the Newest Release of GUI Email 
The lnfonnation Services Department would like to invite you 
to experience the newest release of GUI email. This newest 
version takes minutes to install and provides many new 
enhancements-- all done in response to user requests. GUI 
email opens the door to allow you to keep your existing mail 
files, yet provides you with a Windows-based interface to all 
the luxuries that come with Windows: attachments (Word 
documents, spreadsheets, pictures), PC composition options 
(choice of fonts, colors, spell check, margins, etc.), archive of 
your own files off-line if you wish (locally), and printing to local 
printers (even in color, if one is available to you). 
lnfonnation Services would like to especially welcome on 
board those of you who are still using the original email display 
("Green Screen") and hope you will allow 1/S to bring your PC 
up to the best it can be. Some are still usi~g th~ original . 
version to print to an old nearby Fax mach1ne (v1a T###), wh1ch 
is a carryover from the old days of five to seven years ago 
when printers weren't as common, and it was your only option 
to print locally. If you are among this group and are still 
plugging away with the original green screen versi?n and . 
printing to your old Fax machine, please contact e1ther Bame 
Borger (Barrie.Borger@lvh.com, (610) 402-5715), or Rob Bortz 
(Rob.Bortz@lvh.com, (610) 402-1482). One of these 
individuals will schedule you STAT, ahead of the rest, to 
replace these old, costly fax prints. 
lnfonnal drop-in sessions, designed to help people convert to 
the GUI E-mail from the older emulation system, have been 
scheduled: Monday, May 7, from 1 to 3:45 p.m., and 
Thursday, May 10, from 12:45 to 3:30p.m., both in Classroom 
1 at Cedar Crest & 1-78. Everyone is welcome to drop in 




Mark A. Gittleman, MD, Division of General Surgery, has 
been elected a Governor to the American College of Surgeons, 
representing the American Society of Breast Surgeons. 
Thomas D. Meade, MD, Division of Orthopedic Surgery, 
Section of Ortho Trauma, was recently appointed to sit on the 
Executive Committee of the Alumni Association of Jefferson 
Medical College. Jefferson Medical College boasts the largest 
medical alumni association in the country. 
Papers, Publications and Presentations 
John A. Altobelli, MD, Division of Plastic Surgery, attended 
the Third International Congress of the Society of Pelvic 
Dysfunction in Cairo, Egypt, from March 14-18. He 
participated in the panel on "Pelvic Reconstruction Following 
Large Defects Following Removal of Cancer and Muscle 
Transposition for Incontinence." 
Keith R. Doram, MD, Chief, Division of General Internal 
Medicine, along with two LVH Internal Medicine residents -
David Shields, MD, and lmhotep Boukman, MD -- presented 
two posters at the 21st Annual Regional Meeting of the Society 
of General Internal Medicine, held on March 16, at the 
University of Pennsylvania campus in Philadelphia. The 
posters were titled "Factors Associated with Colorectal Cancer 
Screening Compliance" and "Colorectal Cancer Screening: 
Urban vs. Rural Population. • 
In addition, Dr. Doram and Yehia Y. Mishriki, MD, Division of 
General Internal Medicine/Geriatrics, were co-authors of a 
chapter in the recently released 3rd Edition of John Noble's 
Textbook of Primary Care Medicine. The title of the chapter 
is "Primary Care of the Eye." 
Kelly M. Freed, MD, Division of Diagnostic Radiology, co-
authored two articles. "MRI of Conjoined Twins Illustrating 
Advances in Fetal Imaging," which was published in the 
January 2001 issue of the Journal of Computer Assisted 
Tomography, reviewed two cases of thoracoomphalopagus 
twins. The first case, imaged a decade ago, required the use 
of an intrauterine paralytic agent to reduce fetal motion. This 
intervention is made obsolete by the advent of fast scanning 
techniques which can provide fetal images in seconds. 
The second article, "Nonenhanced Helical CT and US in the 
Emergency Evaluation of Patients with Renal Colic: 
Prospective Comparison," which was published in the 
December 2000 issue of Radiology, evaluated 45 patients by 
CT and US examination (kidney, ureters, bladder including 
ureteral jets). The conclusion made was that noncontrast CT 
was 96% sensitive in the diagnosis of nephroureterallithiasis 
whereas ultrasound was 61% sensitive. 
~liA 
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Mark A. Gittleman, MD, Division of General Surgery, was an 
invited speaker at the TriCare Mid-Atlantic Region Breast 
Imaging Training Seminar held in Virginia Beach, Va., on 
March 8 and 9, where he presented "New Trends in Breast 
Cancer Diagnosis and Treatment." In addition, Dr. Gittleman 
was an invited participant and presenter at the International 
Consensus Conference on Image-Detected Breast Cancer, 
sponsored by the University of Southern California 
Comprehensive Cancer Center, held in Palm Beach, Fla., 
March 22-24. 
Gary S. Greenberg, DPM, Division of Orthopedic Surgery, 
Section of Foot and Ankle Surgery, spoke at the meeting of the 
Council of Teaching Hospitals of the American Association of 
Colleges of Podiatric Medicine in Chicago on March 16 and 17. 
Dr. Greenberg presented a lecture on evaluation of the 
resident, and conducted several workshops on developing 
faculty as educators. 
Geoffrey G. Hallock, MD, Division of Plastic Surgery, recently 
had an article published in the Journal of Plastic and 
Reconstructive Surgery titled "The Plastic Surgeon of the 
20th Century," which was originally presented at the American 
Association of Plastic Surgeons' meeting in Laguna Niguel, 
Calif. 
Vincent R. Lucente, MD, Acting Chairperson, Department of 
Obstetrics and Gynecology, was the Visiting Professor for 
Grand Rounds at the Greater Baltimore Medical Center on 
March 16, where he lectured on "New Concepts in Lower 
Urinary Tract Infections." 
Upcoming Seminars, Conferences and 
Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room at Lehigh Valley Hospital-Muhlenberg. 
Topics to be discussed in May will include: 
•!• May 1 - "Colorectal Cancer Surveillance: Who Gets 
Colonoscopy" 
•!• May 8 - Stahler Rex Lecture -- "Where is the Genetic 
Revolution Headed: Testing, Therapy and Engineering" 
•!• May 15 - "Unanswered Questions" 
•!• May 22 - "Recent Advances in Bacterial Meningitis" 
•!• May 29 - "Approach to Peripheral Neuropathy" 
For more information, contact Diane Biernacki in the 
Deparmtent of Medicine at (610) 402-5200. 
Pediatric Grand Rounds 
"Novel Treatments for Atopic Dermatitis" will be presented on 
Tuesday, May 15, beginning at 8 a.m., in the hospital's 
Auditorium at Cedar Crest & 1-78. 
For more information, please contact Kelli Ripperger in the 
Department of Pediatrics at (61 0) 402-2540. 
Guidelines to Respond to Critical Tetanus Vaccine Shortage for Adults and Adolescents 
1. Anyone with three or more tetanus shots in the past will NOT need a Td booster (during the shortage) 
2. Persons with 0, 1, 2 , or UNKNOWN prior tetanus shots WILL NEED a Td booster as part of wound management, prenatal, 
travel, school, or occupational assessment 
3. TETANUS PRONE wounds** require TIG (tetanus immune globulin) regardless of any need or lack of need for Td 
immunization (** burns, avulsions, crush injury, penetrating wounds, neglected wounds, wounds contaminated with dirt or 
feces, farm implement associated injuries, thermal injuries, electrical injuries). 
It is strongly recommended that health care facilities take inventory of existing supplies of Tetanus vaccine and contact suppliers if 
you foresee a shortfall using criteria of past usage needs. 
Vaccine boosters that may be delayed by the shortage should be agendized for early 2002 for affected patients with a careful 
explanation given the patient of the need to "catch up." 
Presently, pediatric vaccine and guidelines seem unaffected by shortage predictions, but this may change with new information 
and is unclear at present. 
If you have any questions regarding this issue, please contact Luther V. Rhodes Ill, MD, Chief, Division of Infectious Diseases, at 
(610) 402-8430, pager (610) 778-7291, or via email atluther.rhodes@lvh.com. 
Who's New 
The ~ho's New section of Medical Staff Progress Notes 
co~tam~ an update of new appointments, address changes, 
res1gnat1ons, etc. Please remember to update your directory 
and rolodexes with this information. In addition, the Medical 
Staff Directory is now available on the e-mail Bulletin Board --
Directories. Updates will be made to the Medical Staff 
Directory in e-mail at the beginning of each month. 
Medical Staff 
Practice Changes 
Bmdjar & Freeman Medical Associates, P.C. 
(assumed practice of Dr. John M. Kauffman, Jr.) 
);;> Jon E. Bmdjar, DO 
);;> James J. Freeman, DO 
);;> Maria L. Jones, MD 
Jon E. Bmdjar, DO 
1210 S. Cedar Crest Blvd. 
Suite 3700 
Allentown, PA 18103-6237 
(610) 402-0011 
Fax: (61 0) 821-1186 
James J. Freeman, DO 
Maria L. Jones, MD 
4 W. Main Street 
Macungie, PA 18062-1309 
(610) 967-4993 
Fax: (610) 967-6553 
Amitabha Gupta, MD 
(no longer affiliated with Andrew S. Kimmel, MD) 
1588 Woodfield Drive 
Bethlehem, PA 18015-5550 
(610) 997-0381 
David Meir-Levi, DO 
(no .longer with Progressive Physician Associates Inc.) 
Penpheral Vascular Surgeons, PC 
1259 S. Cedar Crest Blvd., Suite 301 
Allentown, PA 18103-6260 
(610) 439-0372 
Fax: (610) 439-8807 
(Effective 5/1/2001) 
Mamie P. O'Brien, DO 
Ooining Lehigh Valley Ophthalmic Associates - 4/30/2001) 
400 N. 171h Street, Suite 101 
Allentown, PA 18104-5099 
(610) 433-0450 
Fax: (610) 433-4655 
Address Change 
James K. Hoffman, MD 
Valley Sports & Arthritis Surgeons 
2649 Schoenersville Road 
Suite 101 
Bethlehem, PA 18017-7326 
(610) 317-3440 
Fax: (610) 317-3443 
Status Change 
William Gee, MD 
Department of Surgery 
Division of Vascular Surgery 
From: Active/LOA 
To: Honorary 
Peter K. Ghatak, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Affiliate 
To: Honorary 
Christine E. Hinke, MD 
Department of Medicine 
Division of Physical Medicine-Rehabilitation 
From: Provisional Active 
To: Associate 
Site of Privileges - L VH-M 
Two-Year Leave of Absence 
Philip L. Tighe, DMD 
Department of Dentistry 
Division of General Dentistry 
Resignation 
Colin Kopes-Kerr, MD 
Department of Family Practice 
(Continued on Page 13) 
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Allied Health Staff 
Appointments 
Jelena Dinic, CRNP 
Physician Extender 
Professional- CRNP 
(Allentown Anesthesia Associates Inc- Lisa A. Keglovitz, MD) 
Site of Privileges - LVH & LVH-M 
Joshua Singer, DC, CNIM 
Physician Extender 
Technical 
Intraoperative Neurophysiological Monitoring Specialist 
(Surgical Monitoring Associates) 
(Supervising Physician - Mark C. Lester, MD) 
Site of Privileges - LVH & LVH-M 
Baoqing Wang, MSc, DABNM 
Associate Scientific 
Clinical Neurophysiologist 
(Surgical Monitoring Associates) 
(Supervising Physician- Mark C. Lester, MD) 
Site of Privileges - LVH & LVH-M 
Lawrence R. Wierzbowski, AuD, DABNM 
Associate Scientific 
Clinical Neurophysiologist 
(Surgical Monitoring Associates) 
(Supervising Physician - Mark C. Lester, MD) 
Site of Privileges - LVH & LVH-M 
Six-Month Leave of Absence 




Janet S. Clark, RN 
Physician Extender 
Professional 
(John J. Cassel, MD, PC) 
Patricia L. Donley, RN 
Physician Extender 
Professional 
(ABC Family Pediatricians- Scott Brenner, MD) 
Margery A. Fettig, RN 
Physician Extender 
Professional 
(John J. Cassel, MD, PC) 
Ruth A. Gerchufsky, RN 
Physician Extender 
Professional 
(The Heart Care Group, PC) 
Deborah R. Miller, CRNP 
Physician Extender 
Professional 
(ABC Family Pediatricians - Donald L. Levick, MD) 
Karen A. Moffat, RN 
Physician Extender 
Professional 
(Yeisley Carcliothoracic Surgery, LLC) 
Angela M. Toro, CRNP 
Physician Extender 
Professional 
(Oncology Specialists of Lehigh Valley) 
M. Deborah Vilegi·Abad, RN 
Physician Extender 
Professional 
(Raul M. Abad, MD) 









Thankfully, I have many opportunities to work with our Hospice Home Care team. Why 
thankfully? Because without their support I would not have the resources I need to care 
for my patients throughout the continuum of their cancer care. 
Many of you use and appreciate these services-and for you, it takes no further 
explanation of why Hospice is so important to our community. 
Many others of you refer to Hospice, and your patients benefit from the care and 
support which Hospice provides. 
This letter is being written both to thank Hospice Home Care for the excellent work they 
do, and to review with my physician colleagues what can be expected of them when 
they make a referral to Hospice Home Care. 
[1] Your patients deserve to live with their terminal illness in comfort and dignity. 
Referral to Hospice well before the crisis of imminent death is always preferred. 
Referral in the crisis of imminent death is understood as sometimes inevitable. 
[2] Referral to Hospice is like any other professional referral, and the same professional 
courtesies are expected. When making a referral, be clear about your role. If you 
intend to continue as the attending of record during Hospice care, please be sure to 
communicate that preference to Hospice intake, or to the person making the referral for 
you. Be prepared to talk with the hospice nurse about your referral to ensure that the 
appropriate care plan is undertaken with your direction. The Hospice nurse should 
never be made to feel that her calling you is an inconvenience. 
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If you intend to refer the patient to another physician, or to the Hospice Medical 
Director, please take the time to make a personal call to the physician who will be 
taking care of your patient to ensure, again, that the care plan you would wish for your 
patient is initiated. An accepting physician should never get an initial call from Hospice 
to the effect that Dr. So and So has referred Mrs. Who and Whom to Hospice, and 
"orders are needed." 
[3] As the course of illness proceeds, care needs for the patient and family may change. 
Again, the Hospice nurse should always feel comfortable communicating these 
changes to you and to ask advice about making changes in the care plan. 
[4] To assist you in your care of the Hospice patient, a small task force under the 
leadership of Dr. Salerno is developing "order sets" which will provide guidelines for you 
and for the nurse for initial management of common symptoms experienced by the 
home hospice patient-such as, nausea, bowel problems, pain, anxiety, and the like. 
These guidelines should lead to more informed communication between you and the 
caring home nurse. 
Last, when you think of Hospice, think of how you would want you or a member of your 
family to be cared for at the time of dying. When that time comes for all of us, we know 
for sure that we will want to be comfortable, and we do not wish to be alone. Hospice 
home care ensures that our patients will be as comfortable as possible, and that the 
patient and family we have cared for will not be alone in their journey. 
Please join me in thanking our Hospice team for their extraordinary efforts, and for 
helping us take better care of our patients. 
Yours Sincerely, 
Gre(£~:2. M~ 
Physician in Chief, Cancer Services 




News from the Library 
OVID Training. 
The Library has completely converted to OVID's on-
line MEDLINE system. This Web-based system is 
updated daily by Ovid. Call Barbara lobst in the 
Health Sciences Library at 610-402-8408 to schedule 
a one-on-one training session. 
New Library Publications. 
CC & I-78 
"Textbook of Natural Medicine," 2nd edition 
L VH-Muhlenberg 
"Sabiston Textbook of Surgery: The Biological Basis of 
Modem Surgical Practice," 16th edition 
17th & Chew Streets 
"DeGowin's Diagnostic Examination," 7th edition 
Computer-Based Training (CBT): 
Computer Based Training (CBT) programs are available for 
L VHHN staff. Topics covered by the CBT programs include: 
Access 2.0 Power-Point 4.0 
Windows NT 4 Word 97 
Excel 97 Access 97 
PowerPoint 97 Lotus 1-2-3 Millennium 
WordPerfect 8 E-mail GUI 
PHAMIS LastWord Inquiry Only commands 
CBT programs replace the instructor-led classes previously 
held at Lehigh Valley Hospital. A proctor will be in the room 
with the learner while he/she takes the CBT, but the learner 
will control the pace and objectives of the learning. 
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Computer Based Training takes place in Suite 401 of the 
John & Dorothy Morgan Cancer Center (the computer 
training room) and in the Muhlenberg Hospital Center 
computer training room (off the front lobby). The schedule 
of upcoming dates is as follows: 
CBT sessions for JDMCC, suite 401 are as follows: 
May 8, 8 am- Noon 
June 26, Noon- 4 pm 
August 7 8 am - Noon 
Sessions at MDC, I.S. Training room are as follows: 
July 17, Noon-4pm 
Twelve slots are available for each session. 
To register, please contact Suzanne Rice via e-mail or at 610-
402-2475 with the following: 
date of session 
second date choice 
department 
phone number 
You will receive an e-mail conlmning your choice within two 
business days. If you have any questions, please contact Craig 
Koller at 610-402-2413 or through e-mail. 
Any questions, concerns or comments on articles from CEDS, please 
contact Bonnie Schoeneberger 610-402-2584 
Sunday Monday Tuesday Wednesday 
May 2001 
1 2 
7am Family Practice GR -
JDMCC 1AIB 
7am Surgical GR-CC-Aud 
Bam Pediatric GR-CC-Aud 
12 noon Medical GR-CC-
Aud 
6 7 8 9 
12noon Colon/Rectal 7am Surgical GR-CC-Aud 12noon Pulmo TB-
TB-JDMCC-CR1 Sam Pediatric GR-CC-Aud JDMCC-CR1 
12 noon Medical GR-CC-
Aud 
13 14 15 16 
7am Surgical GR-CC-Aud 
Bam Pediatric GR-CC-Aud 
12 noon Medical GR-CC-
Aud 
20 21 22 23 
12noon Colon/Rectal 7am Surgical GR-CC-Aud 
TB-JDMCC-CR1 Bam Pediatric GR-CC-Aud 
12 noon Medical GR-CC-
Aud 
27 28 29 30 
7am Surgical GR-CC-Aud 
Bam Pediatric GR-CC-Aud 


















































NEWS FROM THE 
HEALTH INFORMATION MANAGEMENT 
DEPARTMENT 
(MEDICAL RECORDS) 
Volume 1, Issue 1 
Document Imaging 
Upgrade- LVHCC/17/WG 
The PIM 2.0 Document Imaging Historical Medical 
Record Access and Electronic Chart Completion 
System will be upgraded on Tuesday, 
May 15,2001 to the EPF PIM 4.0 system 
Data Conversion 
Tuesday 5/8/01-Monday 5/14/01 
During the data conversion period, the Imnet PIM 
2.0 System will continue to be available in a "read 
only" mode with historical medical records from 
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Tuesday, 5/8/01 -Monday 5/14/01 
• Medical record discharges from Sunday, 
May 6, 2001- Monday, May 14,2001 will be 
available at the CC site HIM Department for 
review in the original paper format. 
• Transcribed H&P, DS, Consults, Ancillary 
Results and Lab Cums will continue to be 
available via the Phamis IDX system during 
the downtime. 
• The HIM Department will be staffed at the 
Cedar Crest location 24 hours a day during the 
downtime and data conversion. 
• The HIM Department will have the ability to 
print/fax medical records for patient care and 
release of information. 
• Paper medical records will not be released 
from the HIM Department during downtime 
due to prepping processes for scanning 
following the conversion. Paper medical 
records must be reviewed in the HIM 
Department at the CC site. 
• Abstracts will continue to be sent to the units 
for re-admits either from printed images or 
photocopies of paper records. 
• Requests for paper medical records should be 
made by calling the HIM Department at 402-
8240 (option 3). 




During the downtime and data conversion, 
physicians/clinicians will be unable to access the 
imaging system to complete medical record 
deficiencies. 
• Physicians/clinicians are encouraged to come 
to the HIM Department at the CC site to 
complete any outstanding dictations (history 
and physicals, operative reports, discharge 
summaries, consults, etc.). This will prevent 
interruption in patient care and allow the 
facility to have appropriate documentation to 
avoid delays in the billing/reimbursement 
process. 
• There will be no telephone notification for 
delinquent records from May 7, 2001 -
May 25, 2001 during downtime, conversion, 
and catch-up processes. It is anticipated that 
normal processes will resume the week of 
May 28, 2001. 
Hardware Upgrade 
Information Services will upgrade the hardware 
and clinical workstations to provide increased 
capacity. This upgrade will quadruple the optical 
disk capacity while providing additional servers. 
Software Upgrade 
The software upgrade will provide additional 
features for the clinicians and Health Information 
Management Department. Some of the new 
features that will impact clinicians include: 
• Physician Groups - Allows definition of 
physician groups with the ability to complete 
deficiencies for group members. 
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• AutoSign - Allows automatic presentation of 
documents for electronic signature with the 
ability to sign the entire batch at one time. 
• Demographic Search - Allows more 
functionality, including moving from patient 
to patient on the same screen. 
• User-Defined Record View- Allows users to 
set up and change his/her own record view 
(documents to be viewed). 
• Missing Text- Gives clinician the ability to 
add missing text to imaged documents 
(transcription, written documents, etc.). 
Software Download 
The Window below will appear ifPIM 4.0 has not 
been loaded on the PC you are using. The load 
process will take approximately 10 minutes to 
perform. Please be patient while this process 
completes the installation of the new software. 
NEWS FROM TilE HEALTH 2 
HIM Website 
Visit the Health Information Management home 
site on the L VHHN intranet home page for 
updated information on the document imaging 




Visit the HIM Website on the L VHHN Intranet 
home page for computer based training for 
medical record access and electronic chart 
completion 
L VH-M Implementation 
Implementation of Document Imaging record 
access and physician/clinician electronic chart 
completion is coming in June 17,2001. Stay 
tuned for more information on specific dates, 
training, etc. 
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I~ HealthNetwork _...._.,_, LABORATORIES 
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CHEMISTRY 
LAB .. LINK 
Information And Advice About Our Laboratory 
Effective May 1, 2001 
THYROID TESTING UPDATE 
To simplify thyroid test ordering, effective May 1, 2001 the following codes will be 
utilized: 
lest Name lest Code Normal Range Low End 
Reportable Range 
Thyroid Stimulating Hormone TSH 0.465- 4.680 uiU/ml 0.003 uiU/ml 
T4 , Free (Thyroxine) FT4 0. 78 - 2.19 ng/dl 0.030 ng/dl 
T4 , Total (Thyroxine) T4 5.50 - 11.00 ug/dl 0.300 ug/dl 
T3 , Free (triiodothyronine) FT3 2. 77 - 5.27 pg/ml 0.390 pg/ml 
T3 , Total (triiodothyronine) T3T 0.96- 1.69 ng/ml 0.10 ng/ml 
T" Uptake (thyroid binding index) T3U 23.50 - 40.60% 17.0% 
PLEASE NOTE: 
• The THYROID PROFILE (TH7) which contains a calculated index will 
NO LONGER BE AVAILABLE as of May 1, 2001 due to the increased 
sensitivity of the above tests. 
• The T4 , Total and TSH tests have been removed from the critical call 
back notification list. 




THERAPEUTICS AT A GLANCE 
The following actions were taken at the March 2001 Therapeutics Committee Meeting- Fred Pane, Director of Pharmacy, 






One of the responsibilities of the 
Therapeutics Committee, a Medical Staff 
Committee, is to assist the Pharmacy 
Department in identifying Operations 
Improvement (01) and implementation. 
A number of programs have been successful, 
in helping to generate an estimated savings 
of$669,877 over the last 18 months at 
Lehigh Valley Hospital and $110,047 at 
Lehigh Valley Hospital - Muhlenberg. 
For the first 6 months ofFY'01 (July to 
December) an estimated $377,758 was 
achieved, through the support of the Medical 
Staff, at Lehigh Valley Hospital, alone. 
Some of the ongoing 01 projects include: 
a) Therapeutic Substitution of Claforan 
for Rocephin, Levaquin for Cipro, 
Zocor for Lipitor, Zemuron for 
Nimbex (ventilator patients), 
Retavase for tPA (MI's and IR). 
b) IV to oral step down therapy of 
Levaquin, Diflucan, Flagyl, Zofran 
and Zithromax. 
c) Formulary Management 
The pharmacy department continues to 
benchmark with national leaders in 
healthcare and works with groups like The 
Advisory Board in Washington, DC. 
If you have 01 suggestions, please contact 
Fred Pane, R.Ph., Director of Pharmacy at 
610-402-8881. Thank you for your ongoing 
support. 
01 Project Examples: 
Cost/day 
A. Claforan 1gm Q8H IV $18.00 
Claforan 1gm Q12H IV 
(renal dose) $12.00 
Rocephin 1gm Q24H IV $38.85 
(restricted to Pediatrics and 
Meningitis) 
B. Levaquin 500mg Q24H IV $15.25 
Levaquin 500mg Q24H PO$ 5.93 
Cipro 400mg Q12H IV $47.00 
(restricted usage) 
C. Zocor 5mg QD PO $0.11 
Zocor 10mg QD PO $0.14 
Zocor 20mg QD PO $0.25 
Lipitor 1 Omg QD PO $1.65 
(not formulary) 
Lipitor 20mg QD PO $2.55 
(not formulary) 
Drug Formulary Issues-
Aggrenox, Pletal, Chirocaine 
Aggrenox (Aspirin 25 mg/extended-
release dipyridamole 200 mg) capsules are 
approved for the reduction of the risk of 
stroke in patients who have had transient 
ischemia of the brain or completed ischemic 
stroke due to thrombosis. 
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CLINICAL PHARMACOLOGY: 
Aspirin and dipyridamole are antiplatelet 
drugs. Aspirin works by irreversibly 
inhibiting the platelet cyclo-oxygenase and 
decreasing the production of thromboxane 
A2• Dipyridamole works by inhibiting the 
reuptake of adenosine into the platelets, 
endothelial cells, and erythrocytes. The 
increased adenosine levels stimulate the 
platelet A2-receptor that activates platelet 
adenylate cyclase and increases the platelet 
cyclic-3 '-5 '-adenosine monophosphate 
(cAMP) levels. This results in the inhibition 
of platelet aggregation. Dipyridamole also 
inhibits phosphodiesterase (PDE) in other 
tissues of the body. The inhibition of cAMP 
and cyclic-3 '-5' -guanosine monophosphate-
PDE (cGMP-PDE) is weak, but the levels of 
each are increased in various tissues. The 
impact on cGMP is greater since 
endothelium-derived relaxing factor (nitric 
oxide) plus dipyridamole can each augment 
the other's activities. 
PHARMACOKINETICS: Peak plasma 
concentrations of aspirin are achieved within 
1 hour. The aspirin is hydrolyzed to 
salicylic acid in the liver and gastrointestinal 
wall. Peak plasma salicylic acid levels are 
reached within 1 hour. The systemic 
bioavailability of aspirin is 50% to 75%. 
The apparent volume of distribution in 10 L. 
The protein binding of aspirin is low, but its 
metabolite (salicylic acid) is highly protein 
bound (90%). The half-life of aspirin is 20 
minutes, and the half-life of salicylic acid is 
1.71 hours at lower doses. The half-life of 
salicylic acid is dose dependent and will 
increase with dose. Peak plasma 
concentrations of dipyridamole are achieved 
within 2 hours with the extended-release 
formulation. The peak plasma 
concentrations are increased by 40% in 
geriatric patients. The steady-state volume 
of distribution is 92 liters. Protein binding is 
99%. The drug does not cross the blood 
brain barrier, but is highly lipophilic. It is 
primarily metabolized by the liver to its 
monoglucuronide, which is a weak active 
metabolite. The terminal half-life of 
dipyridamole is 13.6 hours at lower doses. 
The half-life of salicylic acid is dose 
dependent and will increase with dose. 
Administration of aspirin and dipyridamole 
does not alter the pharmacokinetics of either 
agent. 
ADVERSE REACTIONS: The most 
common adverse effects associated with 
aspirin 25 mg/extended-release 
dipyridamole 200 mg therapy included 
headache, dyspepsia, abdominal pain, 
nausea, diarrhea, and vomiting . A complete 
list of the adverse effects reported with 
aspirin 25 mg/extended-release 
dipyridamole 200 mg can be found in the 
product labeling. 
DRUG INTERACTIONS: No drug 
interaction studies have been conducted with 
the aspirin 25 mg/extended-release 
dipyridamole 200 mg formulation. See the 
drug interactions reported in the product 
labeling; they are based on those reported 
with aspirin or dipyridamole therapy alone. 
DOSING: Aspirin 25 mglextended-release 
dipyridamole 200 mg capsules should be 
given orally twice daily, in the morning and 
evening. Each capsule should be swallowed 
whole and should not be crushed or chewed. 
CONCLUSION: The combination of 
aspirin and dipyridamole may be better than 
aspirin alone in the prevention of stroke in 
patients with a prior history of stroke or TIA 
according to data from the European Stroke 
Prevention study 2 trial. This trial analysis 
was also the basis for a similar declaration in 
the Chest guidelines on stroke prevention 
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(grade lA) Since the studies done with 
Aggrenox used a special formulation of 
aspirin and dipyridamole, the results of these 
trials cannot be applied to the combined use 
of separate prompt-release aspirin and 
dipyridamole products. Clinical 
comparisons of this formulation with 
ticlopidine and clopidogrel are not available. 
Pletal (Cilostazol) is approved for use in the 
treatment of intermittent claudication. The 
drug is also being studied for use in post-
stroke syndrome, the prevention of recurrent 
stroke, prevention of thrombosis and 
restenosis after stent placement, prevention 
of restenosis after angioplasty and the 
prevention of graft occlusion. 
CLINICAL PHARMACOLOGY: 
Cilostazol is a potent and selective inhibitor 
of cGMP-inhibited cAMP 
phosphodiesterase (PDE type 3, PDE3). 
Cilostazol inhibits platelet aggregation, 
including platelet aggregation induced by 
stress, ADP, collagen, arachidonic acid and 
epinephrine. 
PHARMACOKINETICS: Peak plasma 
concentrations occur 2 to 4 hours after oral 
administration. Absorption appears 
unaffected by administration with food. 
Peak anti-aggregatory effects are observed at 
6 hours after oral administration. Cilostazol 
is extensively plasma protein bound, 
primarily to albumin. The mean terminal 
half-life is 12 to 26 hours, although it has 
not been well characterized due to apparent 
biphasic elimination. The distribution half-
life is 2 to 3 hours, and the terminal half-life 
is 18 to 26 hours. Cilostazol is metabolized 
primarily by hydroxylation to numerous 
metabolites, which have half-lives 
comparable to the parent drug. Unchanged 
cilostazol is not detected in the urine. 
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Pharmacokinetics have not varied with age 
or by gender. 
ADVERSE REACTIONS: The most 
common adverse effects are headache, 
diarrhea, abnormal stools (loose stools), 
palpitation and dizziness, with headache 
occurring most frequently. Discontinuation 
of therapy due to side effects was reported 
for 16% of cilostazol-treated patients 
compared to 9% of placebo-treated patients 
in clinical trials. Headaches were most 
frequently described as mild and responded 
to nonprescription analgesics. Animal 
studies have shown cardiovascular lesions, 
including endocardial hemorrhage, 
hemosiderin deposition and fibrosis in the 
left ventricle, hemorrhage in the right atrial 
wall, hemorrhage and necrosis of the smooth 
muscle in the wall of the coronary artery, 
intimal thickening of the coronary artery and 
coronary arteritis and periarteritis. 
Pregnancy data are not currently available. 
In animal studies, cilostazol was excreted in 
breast milk at concentrations of 41% to 72% 
of blood concentrations. 
DRUG INTERACTIONS: Drugs that 
inhibit the CYP3A4 and CYP2C19 
isozymes will decrease the clearance and 
increase the peak plasma concentrations of 
cilostazol or its metabolite. Examples of 
CYP3A4 inhibitors are ketoconazole, 
itraconazole, erythromycin, diltiazem and 
grapefruit juice. An example of a CYP2C19 
inhibitor is omeprazole. Erythromycin 
increases the peak plasma concentration of 
cilostazol by 47% and the AUC by 73% and 
increases the AUC of the 4'-trans-hydroxy-
cilostazol by 141%. Diltiazem increases the 
peak plasma concentration by 53% 
Omeprazole does not affect the metabolism 
of cilostazol, but does affect the elimination 
of the 3 ,4-dehydro-cilostazol metabolite. 
The levels of this metabolite are increased 
by 69%. Aspirin plus cilostazol may further 
decrease platelet aggregation, but it has no 
clinically significant impact on bleeding 
time compared to aspirin alone. 
DOSING: Cilostazol has been dosed at 100 
mg twice daily in the treatment of 
intermittent claudication and in the 
treatment of ischemic symptoms such as 
ulcer, pain and cold sensation due to severe 
peripheral arterial disease. The 
recommended adult dosage of cilostazol is 
100 mg twice daily. The tablet should be 
taken at least half an hour before or 2 hours 
after breakfast and dinner. A lower dose (50 
mg twice daily) should be considered if the 
patient is receiving concurrent therapy with 
ketoconazole, itraconazole, erythromycin, 
diltiazem or omeprazole. The patient should 
also be instructed to avoid grapefruit juice. 
Safety and effectiveness studies have not 
been conducted in children. 
CONCLUSION: Cilostazol appears to 
produce moderate improvements in walking 
distance in patients with intermittent 
claudication and may prove useful as an 
alternative to pentoxifylline in this 
indication. Recent mutlticenter, randomized, 
placebo-controlled trials have shown its 
benefits with stable PAD compared with 
placebo and pentoxyfylline. 
Dr Shaheen presented data on 200 patients 
that were treated with Chirociane 
(levobupivicaine) vs. ropivicaine for 
peripheral nerve blocks. According to his 
presentation, patients receiving 
levobupivicaine obtained a satisfactory level 
of blockade comparable to bupivicaine and 
ropivicaine. Additonally, the duration of 
action was comparable to bupivicaine, but 
this activity was provided without concerns 
related to the potential cardiotoxicity 
associated with large instillations of 
bupivicaine. The duration of effect was 
superior to that associated with ropivicaine, 
and can be provided at a lower cost 
compared with that agent. 
INDICATIONS: Levobupivacaine is 
indicated for the production of local or 
regional anesthesia for surgery and 




Bupivacaine is a racemic agent composed of 
R-(+) and S-(--) enantiomers. 
Levobupivacaine (S-( --)-bupivacaine) is an 
enantiomer of bupivacaine. Due to its long 
duration of action, bupivacaine is the most 
frequently used local anesthetic in epidural 
and peripheral nerve anesthesia; however, it 
is associated with considerable central 
nervous system and cardiovascular toxicity. 
The R-(+) enantiomer ofbupivacaine is 
associated with greater CNS and cardiac 
toxicity. R-(+) bupivacaine is more potent 
than S-( --)-bupivacaine with regard to 
blocking of sodium and potassium channels. 
Because the R-(+) enantiomer is more potent 
at blocking cardiac sodium channels, the S-
( --) enantiomer was pursued in hopes it 
would be associated with less cardiac 
toxicity. Ropivacaine, a propyl homologue 
of bupivacaine, is also an S-( --)-enantiomer 
which offers an improved safety profile 
compared to bupivacaine. 
In animal studies, bupivacaine decreases 
cardiac output, myocardial contractility, 
myocardial blood flow, and intracardiac 
conduction velocity, and induces ventricular 
arrhythmias. Levobupivacaine also induced 
QRS widening and ventricular arrhythmias, 
but at higher doses than bupivacaine and the 
reactions occurred less frequently and were 
less severe. In animal studies, 
levobupivacaine was also associated with 
less CNS toxicity than bupivacaine. 
Levobupivacaine causes more 
vasoconstriction than the other enantiomer, 
resulting in delayed drug uptake from the 
site of administration and prolonged clinical 
effect 
No studies compared levobupivacaine and 
ropivacaine. 
CONTRAINDICATIONS, WARNINGS, 
AND PRECAUTIONS: Levobupivacaine 
is contraindicated in patients with a known 
hypersensitivity to levobupivacaine or to 
any local anesthetic of the amide type. 
Levobupivacaine should not be used for 
intravenous regional anesthesia (bier block) 
or for obstetrical paracervical block 
anesthesia. 
Unintended intravenous injection may result 
in cardiac arrest. Prolonged resuscitation 
may be required. Levobupivacaine should 
be administered in incremental doses. Since 
it should not be injected rapidly in large 
doses, it is not recommended for use in 
emergency situations where a rapid onset is 
desired. 
Levobupivacaine should be used with 
caution in patients with hepatic dysfunction, 
hypotension, hypovolemia, or impaired 
cardiovascular function, particularly heart 
block. 
Levobupivacaine is included in Pregnancy 
Category B. Caution is recommended when 
levobupivacaine is administered to a nursing 
woman. The excretion oflevobupivacaine 
or its metabolites in human milk has not 
been studied. 
The safety and effectiveness of 
levobupivacaine in pediatric patients have 
not been studied. 
ADVERSE REACTIONS: Adverse 
effects observed in more than 5% of 
levobupivacaine-treated patients in studies 
have included hypotension, nausea, post-
operative pain, fever, vomiting, anemia, 
pruritus, pain, headache, constipation, 
dizziness, and fetal distress. 
Levobupivacaine may produce small 
increases in the PR interval and the 
corrected QT interval. 
In animal studies, convulsions and 
excitatory CNS symptoms occurred at a 
lower dose with bupivacaine than with 
levobupivacaine. 
DRUG INTERACTIONS: Although 
studies have not been conducted, it is likely 
that CYP3A4 inducers and inhibitors and 
CYP1A2 inducers and inhibitors may affect 
the metabolism of levobupivacaine. 
DOSING: Dosage recommendations for 
levobupivacaine are included in the product 
labeling and vary according to its indication 
for use. 
CONCLUSION: Dr Shaheen presented 
some data for use of levobupivicaine in lieu 
of ropivicaine in selected procedures. 
Levobupivicaine appeared to provide a level 
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of effectiveness comparable with 
bupivicaine and ropivicaine without the 
potential cardiotoxicity of the former and for 
a longer period of time than the latter. 
Additionally, levobupivicaine provided a 
cost advantage vs. ropivicaine in the 
population observed. 
Drug interactions with enteral products 
A revision to the policy coordinating the 
time of administration of selected 
medications with enteral feedings was 
approved. Pharmacy will be placing an 
interaction notice on the Nursing Medication 
Administration Record (MAR) to more 
clearly identify 'problem' issues and the 
recommended resolutions. A copy of the 
notification form is included below: 
Lehigh Valley Hospital-Muhlenberg 
Hospital 
Enteral Feeding/Drug Interaction Notice 
Patient N arne: -----------------------Nursing Area: ____ _ 
Date: ----------------------
As per the Therapeutics Committee, the 
following agents have been identified as 
requiring administration on an "empty 
stomach". Your patient is currently 
receiving the drug(s) checked below. 
Please, follow the instructions 
appropriate to each item and adjust your 
MAR accordingly. If you have any 
questions, please, contact the Pharmacy. 
___ lansoprazole (Prevacid)-stop tube feeding 
l hour per- and post dose. 
___ phenytoin (Dilantin)- stop tube feeding 2 
hours pre- and post dose 
___ theophyllin- stop tube feeding l hour 
pre- and post dose. 
___ levothyroxine (Synthroid, Levoxyll -stop 
tube feeding l hour pre- and post dose 
___ digoxin (Lanoxin)- stop tube feeding 1 
hour pre- and post dose. ONLY IF SUPPLEMENT 




stop tube feeding 30 minutes pre- and 1 hour 
post dose. 




Pennsylvania Medical Society Physician Alert 
(This information is bring provided to you by Robert X. Murphy, Jr., MD, OMSS Representative) 
Subject: Medical Liability Matters 
Liability Reform Action Center: 1-800-566-TORT (8678) 
State Society's Medical Liability Reform Legislation Readied for Spring 2001 Introduction 
While opposing several ill-advised CAT Fund reform measures now under House and Senate committee 
study, the Society is readying its legislative proposal for medical liability reform for introduction. The 
Society's proposal includes: 
* CAT Fund reforms, and possibly abolishment, without financially burdening physicians, 
particularly young physicians who had nothing to do with the current crisis. 
* A collateral source rule that allows juries to be informed if the victim will be compensated by 
other sources for losses such as wages and health care costs. 
* A voluntary arbitration system that would be binding only if the patient chooses to sign a 
contract. Act 111 of 1975 included mandatory binding arbitration, but that portion of the measure was 
struck down by the courts. 
* An expert witness rule that requires the witness to be board-certified if appropriate, and have the 
same qualifications as the defendant. 
* Measures to clarify informed consent language in the existing law. 
* Compensation for the PIC and PIE insolvencies to offset one year of these costs. 
* Measures to strengthen the medical, osteopathic, and podiatric boards that would enable the 
boards to hire additional staff and to fully implement the boards' authority. 
* An exemption for retired physicians from current mandatory CAT Fund participation. 
The Society's legislative strategy is a multi-phase approach, with the initial measure introduced in 2001 
and successive long-term measures. We believe that the answer to gaining medical liability reform lies in 
a mix of medical liability insurance, tort, and CAT Fund reforms that are strong enough to withstand 
attempts by the legislature to water them down and by the courts to strip them of any authority. 
At the same time that our initial legislative measures move forward, we will continue to work toward 
judicial and legal system reforms, greater public awareness of the urgent need for reform, and developing 
patient safety and quality initiatives. 
Key to the Society's long-term campaign is the enactment of a constitutional amendment to remove the 
state's prohibition against caps on non-economic damages. Because this requires a multi-year legislative 
procedure and a public referendum, the Society is preparing to commit substantial resources to this goal. 
Watch for further details as the Society moves these reforms forward in the next few weeks. Go to 
http:/ /www.lrac@pamedsoc.org/ www.lrac@pamedsoc.org, or call the LRAC for more 
information at 1-800-566-TORT (8678). 
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Doctors Descend on Lawmakers in Capitol on Tuesdays 
On Tuesday, March 13, the halls of the Capitol were dotted with white coats as more than 120 physicians 
from southeastern Pennsylvania loudly warned lawmakers of the urgent need to "Save Pennsylvania 
Medicine." This was not a rally on the scale of the 1996 "Tort Reform Now!" statewide physician rally 
held by the Society, but rather the first in a series of waves of physicians to descend upon Harrisburg's 
legislators on Tuesdays from now until the close of session in May. Another 50 physicians joined the fray 
on March 20, and hundreds more are slated to come later this spring. 
The strategy this time around, said State Society President Carol E. Rose, MD, is to "tell them our 
stories." Physicians must come to Harrisburg to personally tell lawmakers their stories about how the 
medical liability crisis is affecting their ability to serve their patients in their communities. "Tell them 
how you can't recruit a partner; why you're retiring early; how you've put off buying new equipment or 
cut back on higher-risk procedures like delivering babies," Dr. Rose told participants. 
"We couldn't have had a more eloquent, impassioned group of physicians than we had today," Roger 
Mecum, the Society's executive vice president, said following the first "Tuesdays in Harrisburg" event. 
He noted that legislators were responding positively to the physicians' visits, and the event received wide 
media coverage. 
The physicians were also asked to briefly explain to legislators why the Society opposes House Bill 649 
and Senate Bill556. Both bills would privatize the CAT Fund. While the Society supports privatization, 
we believe the bond proposal in HB 649 would be far too costly and would essentially mortgage the 
future for physicians. 
Physicians are urged to join us by region for Tuesdays in Harrisburg. Dates still available are April 24, 
May 1, May 8, and May 22. If you'd like to join us at the Capitol, call the Liability Reform Action Center 
at 1-800-566-TORT (8678) for more information. 
What's Your Story? We Care! 
Our recent experience in the Capitol proves one basic political rule: The story of the individual always 
makes the greatest impact to the press and lawmakers. Physician's individual accounts of how the medical 
liability crisis is changing their relationships with patients and with their communities are the most 
powerful tools we have to get our message across. 
What's your personal story? 
* Has the cost of my medical liability premiums caused my colleagues or me to practice medicine 
differently in 2001 than we did in past years? How has this affected my patients or my community? 
* Has my practice or my hospital, or any other health care facility in my community, had difficulty 
recruiting new physicians? What comments have new doctors made about practicing in Pennsylvania? 
* Have medical liability premiums changed my retirement or business decisions? 
* In five years, if the medical liability crisis continues, what affects to their access to health care 
could my patients expect to suffer? How will my relationship with my patients be different? 
Once you have composed answers to these questions, tell the governor, your patients, your legislators, 
and the State Society your story. It's important to focus on the impact on your patients and your 
community-and to stick to that point! You can make a difference. 
What Can YOU Do? 
Call the governor: Call Tom Ridge at (717) 787-2500. Let him know you will detail your experiences in a 
personal letter. Be sure to fax a copy to the Society at (717) 558-7840. 
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Tell us how the crisis affects your practice and your patients: 
Is it difficult to hire new physicians? Thinking of retiring? Have you cut back on services? Laid off staff? 
Email us at lrac@pamedsoc.org <mailto:lrac@pamedsoc.org> or fax (717) 558-7840, telling us how 
skyrocketing premiums and CAT Fund payments have affected your practice. 
Identify your legislator: To identify your legislator, go to www.pamedsoc.org 
<http://www.pamedsoc.org/>, click on advocacy & information, legislation/regulation, "look up your 
congressman." 
Join P AMP AC: Trial lawyers give generously to their political action committee (PAC). Doctors don't. 
Send a personal contribution to PAMPAC, Box 8820, Harrisburg, PA 17105-8820. 
Help us contact local media: Know any local media personalities? Call Chuck Moran, ext. 1437. 
Come to Harrisburg: Join us at the Capitol-call the Liability Reform Action Center for information at 1-
800-566-TORT. 
Get your patients involved: 
Brochures and posters are available from the LRAC. 
Got Them On Hold? 
Here's a sample of the type of message you can record for those on hold with your office: 
Thank you for holding. We will serve you as quickly as possible. While you wait, you may be interested 
to know that there is a medical crisis in Pennsylvania. The high cost of malpractice insurance is driving 
physicians out of the state. Other physicians aren't doing high-risk procedures anymore. And young 
physicians aren't coming to our state to practice. Politicians in Harrisburg are slow to take action because 
lawyers who sue doctors make big campaign donations. When you can't find a doctor, what will you do? 
Act now. Ask us for details on how you can help save Pennsylvania medicine. 
Answering machine messages for patients 
A very brief message inserted into your answering system may help break the ice in discussing the crisis 
with patients. Here are some suggestions: 
Message 1: Hello. You have reached [name of practice]. Our top priority is preserving a positive 
relationship with our patients. That's getting harder and harder in the face of the medical liability crisis in 
Pennsylvania. Ask us for details .... 
Message 2: Hello. You have reached [name of practice]. When you come to see us, please ask us about 
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